NO792260L - Fremgangsmaate ved utvinning av en naturlig forekommende polar fraksjon med antipsoriatisk virkning - Google Patents

Fremgangsmaate ved utvinning av en naturlig forekommende polar fraksjon med antipsoriatisk virkning

Info

Publication number: NO792260L
Authority: NO; Norway
Prior art keywords: polypodium; extraction; solution; rhizomes; evaporated
Prior art date: 1978-07-07

Application number

NO792260A

Other languages

English (en)

Norwegian (no)

Inventor

Francisco Ramon Alvara Salgado

Blanca Zoila Ney Rivera

Antonio Horvath Sumi

Original Assignee

Conrad Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-07-07

Filing date

1979-07-06

Publication date

1980-01-08

1979-07-06 Application filed by Conrad Ltd filed Critical Conrad Ltd

1980-01-08 Publication of NO792260L publication Critical patent/NO792260L/no

Links

238000000605 extraction Methods 0.000 title claims description 8
230000002682 anti-psoriatic effect Effects 0.000 title claims description 5
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 34
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
239000000243 solution Substances 0.000 claims description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
238000000034 method Methods 0.000 claims description 8
239000000203 mixture Substances 0.000 claims description 8
239000007787 solid Substances 0.000 claims description 8
239000000284 extract Substances 0.000 claims description 6
239000002904 solvent Substances 0.000 claims description 6
239000000463 material Substances 0.000 claims description 5
238000001704 evaporation Methods 0.000 claims description 4
230000008020 evaporation Effects 0.000 claims description 4
239000002245 particle Substances 0.000 claims description 4
238000001035 drying Methods 0.000 claims description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
241000723185 Cyathea Species 0.000 claims description 2
241000487005 Phlebodium decumanum Species 0.000 claims description 2
241000244324 Polypodium aureum Species 0.000 claims description 2
241000592274 Polypodium vulgare Species 0.000 claims description 2
241001362840 Serpocaulon triseriale Species 0.000 claims description 2
239000007864 aqueous solution Substances 0.000 claims description 2
229910052799 carbon Inorganic materials 0.000 claims description 2
239000000706 filtrate Substances 0.000 claims description 2
229940075984 polypodium leucotomos Drugs 0.000 claims description 2
230000008569 process Effects 0.000 claims description 2
239000011347 resin Substances 0.000 claims description 2
229920005989 resin Polymers 0.000 claims description 2
241000737257 Pteris <genus> Species 0.000 claims 1
230000005484 gravity Effects 0.000 claims 1
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
201000010099 disease Diseases 0.000 description 11
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
239000003814 drug Substances 0.000 description 9
229940079593 drug Drugs 0.000 description 9
201000004681 Psoriasis Diseases 0.000 description 8
239000007788 liquid Substances 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
241000196324 Embryophyta Species 0.000 description 5
239000008346 aqueous phase Substances 0.000 description 5
239000000825 pharmaceutical preparation Substances 0.000 description 5
239000012071 phase Substances 0.000 description 5
238000012360 testing method Methods 0.000 description 5
239000004480 active ingredient Substances 0.000 description 4
210000000170 cell membrane Anatomy 0.000 description 4
230000000694 effects Effects 0.000 description 4
239000000126 substance Substances 0.000 description 4
241000699670 Mus sp. Species 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
239000000969 carrier Substances 0.000 description 3
239000013078 crystal Substances 0.000 description 3
239000007903 gelatin capsule Substances 0.000 description 3
239000006193 liquid solution Substances 0.000 description 3
230000001185 psoriatic effect Effects 0.000 description 3
239000003826 tablet Substances 0.000 description 3
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
208000001840 Dandruff Diseases 0.000 description 2
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
241000700159 Rattus Species 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
230000009471 action Effects 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
230000037396 body weight Effects 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
239000002775 capsule Substances 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
239000004744 fabric Substances 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
239000008187 granular material Substances 0.000 description 2
238000005469 granulation Methods 0.000 description 2
230000003179 granulation Effects 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
238000011835 investigation Methods 0.000 description 2
239000006194 liquid suspension Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
238000002156 mixing Methods 0.000 description 2
239000012452 mother liquor Substances 0.000 description 2
206010033898 parapsoriasis Diseases 0.000 description 2
230000008807 pathological lesion Effects 0.000 description 2
239000000843 powder Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
239000000454 talc Substances 0.000 description 2
229910052623 talc Inorganic materials 0.000 description 2
244000215068 Acacia senegal Species 0.000 description 1
229910002012 Aerosil® Inorganic materials 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
239000005995 Aluminium silicate Substances 0.000 description 1
208000036487 Arthropathies Diseases 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
240000001879 Digitalis lutea Species 0.000 description 1
241000393483 Dryopteris crassirhizoma Species 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
208000012659 Joint disease Diseases 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
241000985694 Polypodiopsida Species 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000013543 active substance Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
239000003513 alkali Substances 0.000 description 1
235000012211 aluminium silicate Nutrition 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000003708 ampul Substances 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
230000000059 bradycardiac effect Effects 0.000 description 1
AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
239000000920 calcium hydroxide Substances 0.000 description 1
229910001861 calcium hydroxide Inorganic materials 0.000 description 1
235000011116 calcium hydroxide Nutrition 0.000 description 1
230000000711 cancerogenic effect Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
239000002131 composite material Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000002844 continuous effect Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
230000004090 etiopathogenesis Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000035558 fertility Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000007789 gas Substances 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
229940075507 glyceryl monostearate Drugs 0.000 description 1
230000035876 healing Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
230000002489 hematologic effect Effects 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
239000008101 lactose Substances 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
210000005228 liver tissue Anatomy 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
230000035800 maturation Effects 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
238000002483 medication Methods 0.000 description 1
239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
230000002107 myocardial effect Effects 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
238000010827 pathological analysis Methods 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
239000001814 pectin Substances 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
230000035699 permeability Effects 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000000902 placebo Substances 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000003825 pressing Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000010992 reflux Methods 0.000 description 1
210000005084 renal tissue Anatomy 0.000 description 1
238000011160 research Methods 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
210000004761 scalp Anatomy 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
238000010972 statistical evaluation Methods 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
230000003637 steroidlike Effects 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
230000002110 toxicologic effect Effects 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
238000002562 urinalysis Methods 0.000 description 1
210000003932 urinary bladder Anatomy 0.000 description 1
239000004474 valine Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Natural Medicines & Medicinal Plants (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Tropical Medicine & Parasitology (AREA)
Alternative & Traditional Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Botany (AREA)
Medical Informatics (AREA)
Dermatology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Compounds Of Unknown Constitution (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO792260A 1978-07-07 1979-07-06 Fremgangsmaate ved utvinning av en naturlig forekommende polar fraksjon med antipsoriatisk virkning NO792260L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ES471572A ES471572A1 (es)	1978-07-07	1978-07-07	Procedimiento de obtencion de fraccion polar natural con ac-tividad antipsoriatica

Publications (1)

Publication Number	Publication Date
NO792260L true NO792260L (no)	1980-01-08

Family

ID=8476458

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO792260A NO792260L (no)	1978-07-07	1979-07-06	Fremgangsmaate ved utvinning av en naturlig forekommende polar fraksjon med antipsoriatisk virkning

Country Status (35)

Country	Link
JP (1)	JPS6026376B2 (ro)
AR (1)	AR230188A1 (ro)
AT (1)	AT371715B (ro)
AU (1)	AU4876479A (ro)
BE (1)	BE874483A (ro)
CA (1)	CA1106285A (ro)
CH (1)	CH642085A5 (ro)
CS (1)	CS215008B2 (ro)
DD (1)	DD144719A5 (ro)
DE (1)	DE2900887A1 (ro)
DK (1)	DK180379A (ro)
EG (1)	EG14496A (ro)
ES (1)	ES471572A1 (ro)
FI (1)	FI792128A7 (ro)
FR (1)	FR2434819A1 (ro)
GB (1)	GB2024622B (ro)
GR (1)	GR65334B (ro)
HU (1)	HU179689B (ro)
IE (1)	IE48526B1 (ro)
IL (1)	IL57721A (ro)
IS (1)	IS2495A7 (ro)
IT (1)	IT7919807A0 (ro)
LU (1)	LU81464A1 (ro)
MA (1)	MA18512A1 (ro)
MX (1)	MX5596E (ro)
NL (1)	NL7905251A (ro)
NO (1)	NO792260L (ro)
NZ (1)	NZ190933A (ro)
OA (1)	OA06288A (ro)
PH (1)	PH14338A (ro)
PL (1)	PL124244B1 (ro)
PT (1)	PT69067A (ro)
RO (1)	RO76833A (ro)
SE (1)	SE7903762L (ro)
ZA (1)	ZA793398B (ro)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES470204A1 (es) *	1978-05-24	1979-01-01	Conrad Ltd	Procedimiento de obtencion de terpenos naturales con activi-dad antipsoriatica
ES490293A0 (es) *	1980-04-02	1981-04-16	Conrad Ltd	Un procedimiento de obtencion de un extracto de las fraccio-nes polares de los helechos de la familia polypodiaceae.
NO150880C (no) *	1981-06-01	1985-01-16	Borregaard Ind	Nye aza-krone-etere og anvendelse derav
MC2056A1 (fr) *	1987-12-23	1990-09-04	Psoricur Ltd	Composition therapeutique contre le psoriasis,procede pour sa preparation et utilisation de plantes medicinales qu'elle contient
EP0503208A1 (en) *	1991-03-08	1992-09-16	Maracuyama International, S.A.	Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns
JPH0633820U (ja) *	1992-10-13	1994-05-06	マルヤス機械株式会社	ローラコンベア
EP0680762B1 (en) *	1994-05-06	2002-08-14	Especialidades Farmaceuticas Centrum, S.A.	Pharmaceutical composition comprising fern extract(s) for the treatment of neurodegenerative diseases.
ES2068163B1 (es) *	1994-05-06	1995-09-01	Esp Farmaceuticas Centrum Sa	Procedimiento de obtencion de un extracto vegetal con actividad en el tratamiento de disfunciones cognitivas y/o neuroinmunes.
WO1999006058A1 (es) *	1997-07-30	1999-02-11	Helsint, S.A.L.	Fracciones hidrosolubles de phlebodium decumanum y su empleo como complemento nutricional en pacientes de sida y cancer
ES2137900B1 (es) *	1998-06-02	2000-08-16	Helsint S A L	Empleo de formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum como complemento nutricional en el tratamiento del sindrome caquectico en pacientes oncologicos.
ES2124675B1 (es) *	1997-07-30	1999-10-01	Helsint S A L	"formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum, y su uso en el tratamiento del sindrome caquectico en enfermos de sida".
FR2863163B1 (fr) *	2003-12-04	2006-02-24	Oreal	Composition, notamment cosmetique, comprenant des extraits de fougere et de nacre
FR2876032B1 (fr) *	2004-10-05	2008-10-31	Greentech Sa Sa	Utilisation d'extraits de fougeres dans des preparations cosmetiques ou dermatologiques
US20060246115A1 (en) *	2005-03-04	2006-11-02	Ricardo Rueda	Nutritional products for ameliorating symptoms of rheumatoid arthritis
USD554789S1 (en) *	2006-09-14	2007-11-06	Huo-Tu Huang	Table lamp
AT515350A1 (de) *	2014-02-10	2015-08-15	Christoph Dipl Ing Brandstätter	Verfahren zur Herstellung eines Konzentrats eines Holzschutzmittels, damit hergestelltes Konzentrat und Verfahren zur Behandlung von Holz

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB256768A (en) *	1925-07-17	1926-08-19	Francesco Fumarola	Process for extraction of the active biological principles from the ether extract of male fern
US3395223A (en) *	1965-05-13	1968-07-30	Carter Wallace	Fern extract for treating gastric ulcers
FR2395266A1 (fr) *	1977-06-23	1979-01-19	Suffren Ste Parti Brevets	-lactone monomeres et leurs polymeres, sels et derives, utilisables notamment comme colorants, adjuvants de tannage et medicaments
JPS5464870A (en) *	1977-10-21	1979-05-25	Gte Laboratories Inc	Solid state microwave power supply for electrodeless light source

1978
- 1978-07-07 ES ES471572A patent/ES471572A1/es not_active Expired
- 1978-12-27 AR AR274971A patent/AR230188A1/es active
- 1978-12-28 GR GR57991A patent/GR65334B/el unknown
1979
- 1979-01-11 DE DE19792900887 patent/DE2900887A1/de not_active Withdrawn
- 1979-01-12 PT PT69067A patent/PT69067A/pt unknown
- 1979-01-29 FR FR7902226A patent/FR2434819A1/fr active Granted
- 1979-02-01 IT IT7919807A patent/IT7919807A0/it unknown
- 1979-02-27 BE BE193723A patent/BE874483A/xx not_active IP Right Cessation
- 1979-03-28 CA CA324,314A patent/CA1106285A/en not_active Expired
- 1979-04-27 SE SE7903762A patent/SE7903762L/xx unknown
- 1979-05-02 DK DK180379A patent/DK180379A/da not_active Application Discontinuation
- 1979-05-22 CH CH477779A patent/CH642085A5/de not_active IP Right Cessation
- 1979-05-24 JP JP54064871A patent/JPS6026376B2/ja not_active Expired
- 1979-05-24 GB GB7918174A patent/GB2024622B/en not_active Expired
- 1979-05-29 MX MX798029U patent/MX5596E/es unknown
- 1979-07-04 IL IL57721A patent/IL57721A/xx unknown
- 1979-07-05 FI FI792128A patent/FI792128A7/fi not_active Application Discontinuation
- 1979-07-05 NL NL7905251A patent/NL7905251A/nl not_active Application Discontinuation
- 1979-07-05 LU LU81464A patent/LU81464A1/fr unknown
- 1979-07-05 IS IS2495A patent/IS2495A7/is unknown
- 1979-07-06 OA OA56841A patent/OA06288A/xx unknown
- 1979-07-06 NZ NZ190933A patent/NZ190933A/xx unknown
- 1979-07-06 MA MA18709A patent/MA18512A1/fr unknown
- 1979-07-06 PL PL1979216905A patent/PL124244B1/pl unknown
- 1979-07-06 ZA ZA793398A patent/ZA793398B/xx unknown
- 1979-07-06 CS CS794777A patent/CS215008B2/cs unknown
- 1979-07-06 NO NO792260A patent/NO792260L/no unknown
- 1979-07-06 HU HU79CO371A patent/HU179689B/hu unknown
- 1979-07-06 AT AT0471479A patent/AT371715B/de not_active IP Right Cessation
- 1979-07-07 RO RO7998089A patent/RO76833A/ro unknown
- 1979-07-07 EG EG415/79A patent/EG14496A/xx active
- 1979-07-09 DD DD79214207A patent/DD144719A5/de unknown
- 1979-07-09 AU AU48764/79A patent/AU4876479A/en not_active Abandoned
- 1979-07-09 PH PH22755A patent/PH14338A/en unknown
- 1979-08-08 IE IE1274/79A patent/IE48526B1/en unknown

Also Published As

Publication number	Publication date
CS215008B2 (en)	1982-06-25
IE48526B1 (en)	1985-02-20
GR65334B (en)	1980-08-14
IT7919807A0 (it)	1979-02-01
JPS6026376B2 (ja)	1985-06-24
SE7903762L (sv)	1980-01-08
DK180379A (da)	1980-01-08
PT69067A (en)	1979-02-01
AU4876479A (en)	1980-01-10
IL57721A (en)	1983-07-31
ES471572A1 (es)	1979-01-16
LU81464A1 (fr)	1980-04-21
DD144719A5 (de)	1980-11-05
PL124244B1 (en)	1983-01-31
FI792128A7 (fi)	1981-01-01
OA06288A (fr)	1981-06-30
FR2434819A1 (fr)	1980-03-28
IE791274L (en)	1980-01-07
AR230188A1 (es)	1984-03-01
IL57721A0 (en)	1979-11-30
CH642085A5 (de)	1984-03-30
IS2495A7 (is)	1981-02-06
CA1106285A (en)	1981-08-04
FR2434819B1 (ro)	1982-07-09
NZ190933A (en)	1982-11-23
JPS5511570A (en)	1980-01-26
MX5596E (es)	1983-11-04
PL216905A1 (ro)	1980-04-21
AT371715B (de)	1983-07-25
MA18512A1 (fr)	1980-04-01
NL7905251A (nl)	1980-01-09
ATA471479A (de)	1982-12-15
EG14496A (en)	1984-03-31
GB2024622A (en)	1980-01-16
RO76833A (ro)	1981-05-30
ZA793398B (en)	1981-07-29
DE2900887A1 (de)	1980-01-24
PH14338A (en)	1981-05-29
HU179689B (en)	1982-11-29
BE874483A (fr)	1979-06-18
GB2024622B (en)	1983-03-30

Publication	Publication Date	Title
EP1800685B1 (en)	2012-08-22	Steroidal saponin pharmaceutical composition, its preparation method and use
US4598069A (en)	1986-07-01	Method of treating hypoglycemia using aloes polysaccharides
CA1106285A (en)	1981-08-04	Process for obtaining a natural polar fraction having anti-psoriatic activity
CN101323635A (zh)	2008-12-17	三七皂苷st-4,其药物组合物和其制备方法及其应用
CN101703515B (zh)	2011-12-21	一种脑苷脂类化合物的应用
CN107198696B (zh)	2020-05-29	车叶草苷酸在制备治疗肾纤维化药物中的应用
EP1559703A1 (en)	2005-08-03	A natural compound useful for treating diabetes, its preparation and use
IE48415B1 (en)	1985-01-09	Natural terpenes having an antipsoriatic activity
CN112940001A (zh)	2021-06-11	一种苯酞异喹啉生物碱及其制备方法和应用
CN107708717A (zh)	2018-02-16	神经细胞凋亡抑制剂、抗阿尔茨海默症剂、抗脑功能减退剂、具有抗阿尔茨海默症作用或抗脑功能减退作用的医药品或食品及神经细胞凋亡抑制剂的制造方法
KR100625222B1 (ko)	2006-09-19	신규 짐넴산 유도체, 그 제조 방법, 및 그의 약학적 용도
KR100780056B1 (ko)	2007-11-29	인삼 사포닌 Rg2의 추출방법 및 그 추출물을 포함하는 의약조성물과 그 용도
CN101612184A (zh)	2009-12-30	多舌飞蓬提取物、含该提取物的组合物及制备方法和用途
RU2178709C2 (ru)	2002-01-27	Способ получения вещества, обладающего иммуномодулирующей активностью
KR19980045814A (ko)	1998-09-15	사이트로스테디엔올을 보체 활성 조절제로 사용하는 용도 및 그의 제조방법
CN100369610C (zh)	2008-02-20	一种防治糖尿病的植物提取物及其制备方法与药物用途
JPS627172B2 (ro)	1987-02-16
US20060167104A1 (en)	2006-07-27	Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family and use of N,N'-dibenzylthiourea as a medicine
CN106977560A (zh)	2017-07-25	2S-cardiospermin-5-benzoate的制备及其在制备治疗类风湿关节炎药物中的应用
CN106977561A (zh)	2017-07-25	Sutherlandin-5-p-hydroxybenzoate的制备及其在制备治疗类风湿关节炎药物中的应用
CN106974921B (zh)	2020-11-03	2R-cardiospermin-5-p-hydroxybenzoate的制备及其在制备治疗类风湿关节炎药物中的应用
JPS632928A (ja)	1988-01-07	鎮痛剤
CN106974922B (zh)	2020-12-01	2S-cardiospermin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用
CN106974923B (zh)	2020-11-03	Sutherlandin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用
JPH0261443B2 (ro)	1990-12-20